All Pharma News
BMS cuts hundreds of Mirati staffers shortly after buyout

BMS cuts hundreds of Mirati staffers shortly after buyout
FIERCE PHARMA
27 Mar 2024
Share Share
Bristol Myers Squibb Completes Acquisition of Mirati Therapeutics

Bristol Myers Squibb Completes Acquisition of Mirati Therapeutics
BUSINESSWIRE
23 Jan 2024
Share Share
Bristol Myers gets regulatory clearance to close Mirati deal

Bristol Myers gets regulatory clearance to close Mirati deal
Nicole DeFeudis ENDPTS
20 Dec 2023
Share Share
EU body endorses Mirati`s KRAS drug for lung cancer after second look

EU body endorses Mirati`s KRAS drug for lung cancer after second look
PR NEWSWIRE
11 Nov 2023
Share Share
Kura Oncology and Mirati Therapeutics Enter into Clinical Collaboration

Kura Oncology and Mirati Therapeutics Enter into Clinical Collaboration
GLOBENEWSWIRE
02 Nov 2023
Share Share
Securities filing details BMS` years-long courtship of Mirati

Securities filing details BMS` years-long courtship of Mirati
Fraiser Kansteiner FIERCE PHARMA
24 Oct 2023
Share Share
Mirati Presents Results Evaluating the Combination of Adagrasib in NSCLC

Mirati Presents Results Evaluating the Combination of Adagrasib in NSCLC
PRESS RELEASE
17 Oct 2023
Share Share
Bristol-Myers Squibb to acquire Mirati in up to $5.8 billion deal

Bristol-Myers Squibb to acquire Mirati in up to $5.8 billion deal
REUTERS
09 Oct 2023
Share Share
Sanofi weighs acquisition of Mirati: Bloomberg

Sanofi weighs acquisition of Mirati: Bloomberg
Eric Sagonowsky FIERCE PHARMA
05 Oct 2023
Share Share
Mirati To Present Updated Clinical Data at ESMO Congress 2023

Mirati To Present Updated Clinical Data at ESMO Congress 2023
PRESS RELEASE
27 Sep 2023
Share Share